Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease

作者: Craig Wong , Peter Kanetsky , Dominic Raj

DOI: 10.1007/S00467-008-0816-Z

关键词:

摘要: Chronic kidney disease (CKD) in children is irreversible. It associated with renal failure progression and atherosclerotic cardiovascular (CV) abnormalities. Nearly 60% of CKD are affected since birth congenital or inherited disorders. Preliminary evidence primarily from adult studies indicates common genetic risk factors for CV disease. Although multiple physiologic pathways share genes disease, substantial supports our attention to the renin angiotensin system (RAS) interlinked inflammatory cascade because they modulate progressions Gene polymorphisms RAS-cytokine pathway, through altered gene expression cytokines, potential that rate abnormalities patients CKD. For studying such hypotheses, cooperative efforts among scientific groups availability robust affordable technologies genotype thousands single nucleotide (SNPs) across genome make genome-wide association an attractive paradigm polygenic diseases as attractive, should be interpreted carefully, a fundamental understanding their weaknesses. Nevertheless, whole-genome diabetic nephropathy future pertaining other types will offer further insight development targeted interventions treat pediatric population.

参考文章(141)
Julie E. Buring, Sherry L. Mayrent, Charles H. Hennekens, Epidemiology in Medicine ,(1987)
Kenneth J. Rothman, Sander Greenland, Timothy L. Lash, Case–Control Studies Encyclopedia of Quantitative Risk Analysis and Assessment. ,(2008) , 10.1002/9780470061596.RISK0599
Mark P.S. Sie, Fakhredin A. Sayed-Tabatabaei, Hok-Hay S. Oei, André G. Uitterlinden, Hubert A.P. Pols, Albert Hofman, Cornelia M. van Duijn, Jacqueline C.M. Witteman, Interleukin 6 −174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease: Results from the Rotterdam Study and a Meta-Analysis Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 26, pp. 212- 217 ,(2006) , 10.1161/01.ATV.0000194099.65024.17
F. POCIOT, J. MØLVIG, L. WOGENSEN, H. WORSAAE, J. NERUP, A Taql polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro European Journal of Clinical Investigation. ,vol. 22, pp. 396- 402 ,(1992) , 10.1111/J.1365-2362.1992.TB01480.X
Osamu Takase, Takeshi Marumo, Naohiko Imai, Junichi Hirahashi, Atsushi Takayanagi, Keiichi Hishikawa, Matsuhiko Hayashi, Nobuyoshi Shimizu, Toshiro Fujita, Takao Saruta, NF-κB-dependent increase in intrarenal angiotensin II induced by proteinuria Kidney International. ,vol. 68, pp. 464- 473 ,(2005) , 10.1111/J.1523-1755.2005.00424.X
Joon-Young Park, Iain K. G. Farrance, Nicola M. Fenty, James M. Hagberg, Stephen M. Roth, David M. Mosser, Min Qi Wang, HanJoong Jo, Toshihiko Okazaki, Steven R. Brant, Michael D. Brown, NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 293, ,(2007) , 10.1152/AJPHEART.00186.2007
M. Suthanthiran, Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 3479- 3484 ,(2000) , 10.1073/PNAS.050420897
Baogui Li, Ashwani Khanna, Vijay Sharma, Tejinder Singh, Manikkam Suthanthiran, Phyllis August, TGF-β1 DNA Polymorphisms, Protein Levels, and Blood Pressure Hypertension. ,vol. 33, pp. 271- 275 ,(1999) , 10.1161/01.HYP.33.1.271
François Pompanon, Aurélie Bonin, Eva Bellemain, Pierre Taberlet, Genotyping errors: causes, consequences and solutions. Nature Reviews Genetics. ,vol. 6, pp. 847- 859 ,(2005) , 10.1038/NRG1707